A 2-year study of sertraline in the treatment of obsessive-compulsive disorder

International Clinical Psychopharmacology

Volumn 12, Issue 6, 1997, Pages 309-316

  Rasmussen, S ^a   Hackett, E ^b   DuBoff, E ^c   Greist, J ^d   Halaris, A ^e   Koran, L M ^f   Liebowitz, M ^g   Lydiard, R B ^h   McElroy, S ⁱ   Mendels, J ^j   O'Connor, K ^k  

^a BUTLER HOSPITAL   (United States)

^b Pfizer Central Research   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d Dean Foundation   (United States)

^e METROHEALTH MEDICAL CENTER   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^h MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

ⁱ HARVARD MEDICAL SCHOOL   (United States)

^j Philadelphia Medical Institute   (United States)

^k Hennepin City Medical Center   (United States)

more..

Author keywords

Maintenance treatment; Obsessive compulsive disorder; SRI treatment

Indexed keywords

PLACEBO; SERTRALINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; FATIGUE; FEMALE; HEADACHE; HUMAN; INSOMNIA; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; OBSESSION; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; SWEATING; TREMOR; VERTIGO; XEROSTOMIA;

EID: 14444284109     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199711000-00003     Document Type: Article

References (32)

1. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders, 3rd edn, Revised. American Psychiatric Association Press, Washington.
2. Black A (1974) The natural history of obsessional neurosis. In: Obsessional States (Ed. HR Beech), pp 1-23. Methuen Company, London.
3. Chouinard G, Goodman W, Greist J, Jenike M, Rasmussen S, White K, Hackett E, Gaffacy M and Bick PA (1990) Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder. Psychopharmacology Bulletin, 26, 279-284.
4. The Clomipramine Collaborative Study Group (1991) Efficacy of clomipramine in OCD: results of a multicenter double-blind trial. Archives of General Psychiatry, 48, 730-738.
5. Flament MF, Rapoport JL, Berg CJ, Sceery W, Kitts C, Mellstrom B and Linnoila M (1985) Clomipramine treatment of childhood compulsive disorder. Archives of General Psychiatry, 42, 977-983.
6. Goodman WK, Price LH, Rasmusssen SA, Delgado PL, Heninger GR and Charney DS (1989a) Efficacy of fluvoxamine in obsessive compulsive disorder. A double-blind comparison with placebo. Archives of General Psychiatry, 46, 36-44.
7. Goodman WK, Price LH, Rasmusssen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR and Charney DS (1989b) The Yale-Brown Obsessive Compulsive Scale, I: development, use and reliability. Archives of General Psychiatry, 46, 1006-1011.
8. Goodman WK, Price LH, Rasmusssen SA, Mazure C, Delgado P, Heninger GR and Charney DS (1989c) The Yale-Brown Obsessive Compulsive Scale, II: validity. Archives of General Psychiatry, 46, 1012-1016.
9. Goodwin DW, Guze SB and Robbins E (1969) Follow-up studies in obsessional neurosis. Archives of General Psychiatry, 20, 182-187.
10. Greist JH, Chouinard G, DuBoff E, Halaris A, Kim SW, Koran L, Liebowitz M, Lydiard RB, Rasmussen S, White K et al. (1995a) Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder. Archives of General Psychiatry, 52, 289-293.
11. Greist JH, Jefferson JW, Kobak K, Chouinard G, DuBoff E, Halaris A, Kim SW, Koran L, Liebowitz MR, Lydiard B et al. (1995b) A one-year double-blind, placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder. International Clinical Psychopharmacololgy, 50, 57-65.
12. Greist JH, Jefferson JW, Rosenfeld R, Gutzmann LD, March JS and Barklage NE (1990) Clomipramine and obsessive-compulsive disorder. A placebo-controlled double-blind study in 32 patients. Journal of Clinical Psychiatry, 51, 292-297.
13. Guy W (1976) ECDEU Assessment Manual for Psychopharmacology, Revised. Department of Health, Education and Welfare Publication No. (ABM) 76-338, Rockville.
14. Hollingshead AB (1957) The 2-Factor Index of Social Position. Privately Published, New Haven.
15. Insel TR, Murphy DL, Cohen RM, Alterman I, Kilts C and Linnoila M (1983) Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgline. Archives of General Psychiatry, 40, 605-612.
16. Janet P (1904) Psychastheria and Obsessions, [in French] 2nd edn. Bailliere, Paris
17. Jenike MA, Baer L, Summergrad P, Weilburg JB, Holland A and Seymour R (1989) Obsessive-compulsive disorder. A double-blind placebo-controlled trial of clomipramine in 27 patients. American Journal of Psychiatry, 146, 1328-1330.
18. Jenike MA, Hyman SE, Baer L, Holland A, Minichiello WE, Buttolph L, Summergrad P, Seymour R and Ricciardi J (1990) A controlled trial of fluvoxamine for obsessive-compulsive disorder: implications for a serotonergic theory. American Journal of Psychiatry, 147, 1209-1215.
19. Kringlen E (1965) Obsession neurotics: a long-term follow up. British Journal of Psychiatry, 111, 709-722.
20. Leonard HL, Swedo SE, Lenane MC, Rettew DC, Cheslow DL, Hamburger SD and Rapoport JL (1991) A double-blind desipramine substitution during long-term clomipramine treatment in children and adolescents with obsessive-compulsive disorder. Archives of General Psychiatry, 48, 922-927.
21. Leonard HL, Swedo SE, Rapoport JL, Koby EV, Lenane MC, Cheslow DL and Hamburger SD (1989) Treatment of childhood obsessive-compulsive disorder with clomipramine and desipramine. A double-blind crossover comparison. Archives of General Psychiatry, 46, 1088-1092.
22. Lewis AJ (1936) Problems of obsessional illness. Proceedings of the Royal Society of Medicine, 29, 325-336.
23. Lo WH (1967) A follow-up study of obsessional neurotics in Hong Kong Chinese. British Journal of Psychiatry, 113, 823-832.
24. Murphy DL, Pickar D and Alterman IS (1982) Methods for the quantitative assessment of depressive and manic behavior. In: The Behavior of Psychiatric Patients (Eds E Burdock, A Sudilovsky and S Gershon), pp 355-391. Marcel Dekker, New York.
25. Pato MT, Zohar-Kadouch R, Zohar J and Murphy DL (1988) Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder. American Journal of Psychiatry, 145, 1521-1525.
26. Pato MT, Murphy DL and DeVane CL (1991) Sustained plasma concentrations of fluoxetine and norfluoxetine four and eight weeks after fluoxetine discontinuation. Journal of Clinical Psychopharmacology, 1, 224-225.
27. Perse TL, Greist JH, Jefferson JW, Rosenfeld R and Dar R (1987) Fluvoxamine treatment of obsessive-compulsive disorder. American Journal of Psychiatry, 144, 1543-1548.
28. Pollit J (1957) Natural history of obsessional states. British Medical Journal, 1, 194-198.
29. Rasmussen SA and Tsuang MT (1986) DSM II obsessive-compulsive disorder: clinical characteristics and family history. American Journal of Psychiatry, 143, 317-322.
30. Thoren P, Asberg M, Cronholm B, Jornestedt L and Traskman L (1980) Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial. Archives of General Psychiatry, 37, 1281-1285.
31. Tollefson GD, Rampey AH, Potvin JH, Jenike MA, Rush AJ, Dominguez RA, Koran LM, Shear MK, Goodman W and Genduso LA (1994) A multicentre investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder. Archives of General Psychiatry, 51, 559-567.
32. Weiner A, Reich T, Robins E, Fishman R and Van Doren T (1976) Obsessive compulsive neurosis: record, follow-up, and family studies. I. Inpatient record study. Comprehensive Psychiatry, 17, 527-539.